Martini A, Bonadeo D, Bottoni G, Caramella C, Esposito P, Gazzaniga A, Merlo M, Muggetti L, Orlandi R, Rossi S
Gruppo di Studio Biofarmaceutica A.F.I., Milano.
Boll Chim Farm. 1995 Dec;134(11):595-603.
Pharmaceutical research is going on the way to formulate drugs in dosage forms and delivery systems able to improve their biopharmaceutical properties. For some routes of administration, among them the transmucosal ones, such improvements may be reached by increasing the time and the nature of the contact between mucosal tissues and drug dosage forms via chemical or physical bioadhesive links. Biopharmaceutical AFI Study Group efforts were oriented in analyzing the actual state of the art in the field of bioadhesive drug delivery. Rationals of use of drug dosage forms with bioadhesive properties, analytical method of control of bioadhesion (both in vitro and in vivo) and therapeutical potentialities are the matter of this review.
药物研究正在朝着开发能够改善其生物药剂学性质的剂型和给药系统的方向发展。对于某些给药途径,其中包括经粘膜给药途径,可以通过化学或物理生物粘附连接增加粘膜组织与药物剂型之间接触的时间和性质来实现这种改善。生物药剂学AFI研究小组致力于分析生物粘附药物递送领域的实际技术水平。具有生物粘附特性的药物剂型的使用原理、生物粘附的控制分析方法(包括体外和体内)以及治疗潜力是本综述的主题。